Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-003195

CEO sold 6,164 shares at $69.51 ($428,448)

  • CEO acquired 7,463 shares (option exercise)
  • CEO gave 1,299 shares (gift)
  • CEO gave 1,299 shares (gift)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Zovighian Bernard J · CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Exercise or conversion : show line 1 in the form 10b5-1 +7,463 $45.28 $337,900 66,545.9 D
2025-03-10 Gift : show line 2 in the form 10b5-1 −1,299 65,246.9 D
2025-03-10 Sale : show line 3 in the form 10b5-1 −6,164 $69.51 $428,448 59,082.9 D
2025-03-10 Gift : show line 4 in the form 10b5-1 +1,299 10,436 I
Open-market sales · 6,164 sh · avg $69.51 · $428,448

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-10 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (Right to Acquire) −7,463 7,462 D
Loading xslF345X05/doc4.xml…